lobbying_activities: 3058329

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3058329	8714f57d-1fe6-495e-8647-980c84d21fe8	Q3	WALGREEN COMPANY	309071	WALGREEN COMPANY	2023	third_quarter	PHA	H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.	HOUSE OF REPRESENTATIVES,SENATE		940000	0	0	2023-10-18T17:22:56-04:00